Teresa Company Messa: ”Evolution, Commitment, and Innovation” Perfectly Sum up Last Week’s Event
Teresa Company Messa, Market Development Manager at Werfen, shared on LinkedIn:
”Evolution, commitment, and innovation
Three big words, but ones that perfectly sum up last week’s event: the launch of the 70 Series, a new generation of analyzers that mark another step forward in our mission to advance hemostasis diagnostics.
And there could be no better setting than La Pedrera.
Just as Gaudí challenged the limits of his time to transform architecture, we continue to push the limits of technology to transform diagnostics.
And for those of you who are not part of this world, you may ask yourselves: what does this have to do with me?
Everything.
Because behind every sample there is a person, and that person could be you, it could be me.
At Werfen, we work every day with a firm commitment to ensuring the highest quality, accuracy, and service for laboratory professionals and, ultimately, for patients.”
Stay updated with Hemostasis Today.
-
Jan 10, 2026, 15:02Dr Manikanta Receives AHA Fellowship to Investigate Platelet-Dependent Nucleic Acid-Sensing Pathways
-
Jan 10, 2026, 14:40Last day at ASH25 from Riten Kumar
-
Jan 10, 2026, 08:56Shivanand Kumatagi Reflects on His Visit to Rela Hospital
-
Jan 10, 2026, 08:48Mitchell Elkind: Why Is The American Heart Association Holding a Brain Health Symposium?
-
Jan 10, 2026, 08:41Fiona Robinson Invites You to NBDF Webinar on Research Grants
-
Jan 10, 2026, 08:30Melissa Korn Takes Front Page Award for Her WSJ Piece on Experiencing a Pulmonary Embolism
-
Jan 10, 2026, 08:20Aymar Akilimali on Malaria in the Democratic Republic of Congo
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome